PETALING JAYA: Pharmaniaga Bhd
will focus on targeted initiatives aimed at streamlining business activities to exit its Practice Note 17 (PN17) status.
In a statement, executive committee chairman Ahmad Shahredzuan Mohd Shariff said the pharmaceutical company will optimise its overall business operations and costs, as well as finding synergies across all of its business units.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
